Association between hemoglobin glycation index and the risk of cardiovascular disease in early-stage cardiovascular-kidney-metabolic syndrome: evidence from the China health and retirement longitudinal study
HGI is associated with an elevated risk of CVD in participants with early-stage CKM syndrome. HGI can serve as an independent biomarker for guiding clinical decision-making and managing patient outcomes.
Authors
- Shuai Mao (ORCID: https://orcid.org/0000-0003-3599-0553)
- Chao Lv (ORCID: https://orcid.org/0000-0002-4087-4672)
- Huiyi Liu (ORCID: https://orcid.org/0000-0001-5806-1023)
- Yunzhang Zhao (ORCID: https://orcid.org/0009-0002-2618-6862)
- Yifan Wang (ORCID: https://orcid.org/0000-0001-7387-0654)
- Lisha Dong (ORCID: https://orcid.org/0009-0003-1590-1688)
- Tong Yin (ORCID: https://orcid.org/0000-0001-8275-3476)
Institutions
- Chinese PLA General Hospital (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.3389/fendo.2025.1554032
- Citations
- 2
- Primary Topic
- Advanced Glycation End Products research
- Type
- article
- Field-Weighted Citation Impact
- 2.64
Funders
- General Hospital of People’s Liberation Army
- National Health Commission of the People's Republic of China